切换导航
关闭
  • 菜单
  • Setting

D-Lin-MC3-DMA

 
Catalog No.
A8791
一种有效、可电离的阳离子脂质体,用于体内递送siRNA,也可用于制备纳米颗粒递送mRNA药物等。
组合的产品项目
规格价格库存 数量
5mg
¥ 1,090.00
现货
10mg
¥ 1,636.00
现货
25mg
¥ 3,272.00
现货

电话: 021-55669583

邮箱: sales@apexbio.cn

全球经销商

A

背景

siRNA-based drugs need a complicated delivery vehicle, that’s because it degraded rapidly in the circulation, difficult to cross the cell membranes and enter the cytoplasm, plus inefficient accumulation in target tissues. The major delivery technology for siRNA is the lipid nanoparticle (LNP) containing ionizable amino lipid, which is the consisted of an ionizable amino lipid (heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate, DLin-MC3-DMA), a phosphatidylcholine (1,2-distearoyl-sn-glycero-3-phosphocholine, DSPC), cholesterol and a coat lipid (polyethylene glycol-dimyristolglycerol, PEG-DMG). As a potent siRNA delivery vehicle, DLin-MC3-DMA is 1000-fold more potent for silencing of a hepatic gene (Factor VII), comparing to its precursor lipid DLin-DMA. The ED50 for LNP containing DLin-MC3-DMA to silence Factor VII was 0.005 mg/kg for mice, and 0.03 mg/kg for TTR in non-human primates.

Reference:

Tam YY, Chen S, Cullis PR. Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics. 2013 Sep 18;5(3):498-507. PMID: 24300520.

文献引用

化学属性

StorageStore at -20°C or below
M.Wt642.09
Cas No.1224606-06-7
FormulaC43H79NO2
SynonymsDlin-MC3-DMA; DLin
Solubilityinsoluble in H2O; insoluble in DMSO; ≥152.6 mg/mL in EtOH
Chemical Name(6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate
SDFDownload SDF
Canonical SMILESO=C(CCCN(C)C)OC(CCCCCCCC/C=C\C/C=C\CCCCC)CCCCCCCC/C=C\C/C=C\CCCCC
运输条件 蓝冰运输或根据您的需求运输。
一般建议不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

质量控制